- Home
- Research
- Mental Health
- Latent Classes of Substance Use in Young Adult Survivors of Child Maltreatment and Adversity: A 20-Year Prospective Investigation.
How childhood trauma predicts cannabis and substance patterns
Latent Classes of Substance Use in Young Adult Survivors of Child Maltreatment and Adversity: A 20-Year Prospective Investigation.
AI Summary
This groundbreaking 20-year prospective study followed 483 individuals from age 4 into young adulthood (average age 23.8) to understand how childhood trauma shapes substance use patterns. Researchers tracked participants who experienced child abuse, neglect, or were at high risk for maltreatment, collecting data on adverse childhood experiences (ACEs) from the 1990s through early 2000s. The study identified four distinct substance use patterns in young adulthood: a group with high cannabis and tobacco use (66 participants), a smaller group using heroin and non-prescription opioids (21 participants), a poly-substance use group (21 participants), and the largest group with low overall substance use (375 participants).
The findings reveal a strong prospective link between childhood adversity and problematic substance use in young adulthood. Participants who remained abstainers or low-level users experienced significantly fewer childhood adversities and less exposure to intimate partner violence (IPV) as adults compared to the higher-use groups. Importantly, the cannabis and tobacco use group represented the second-largest category of users, suggesting this combination may be a common response to early-life trauma. These results highlight how early intervention and trauma-informed care could potentially reduce problematic substance use patterns later in life, particularly for individuals with documented childhood maltreatment histories.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Review describes AHC and reports cannabidiol as an additional treatment option
Review finds school prevention often covers cannabis, but evidence gaps remain
Antipsychotics eased symptoms, but relapse-prevention evidence remains thin
Explore More Research
Stay informed about the latest cannabis science.